These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38420532)
1. Unraveling the spectrum of inflammatory myofibroblastic tumors in the lung: A comprehensive case series highlighting endobronchial, pleural, and lung parenchymal tumors. Vounckx M; Jansen YJL; Fadaei S; Geers C; De Pauw V; Smets D JTCVS Open; 2024 Feb; 17():297-305. PubMed ID: 38420532 [TBL] [Abstract][Full Text] [Related]
2. ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors. Alassiri AH; Ali RH; Shen Y; Lum A; Strahlendorf C; Deyell R; Rassekh R; Sorensen PH; Laskin J; Marra M; Yip S; Lee CH; Ng TL Am J Surg Pathol; 2016 Aug; 40(8):1051-61. PubMed ID: 27259007 [TBL] [Abstract][Full Text] [Related]
3. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report. Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760 [TBL] [Abstract][Full Text] [Related]
4. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767 [TBL] [Abstract][Full Text] [Related]
5. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with ETV6::NTRK3 fusion. Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of pan-Trk immunohistochemistry for inflammatory myofibroblastic tumours. Yamamoto H; Nozaki Y; Kohashi K; Kinoshita I; Oda Y Histopathology; 2020 Apr; 76(5):774-778. PubMed ID: 31578734 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors. Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984 [TBL] [Abstract][Full Text] [Related]
9. A unique case of inflammatory myofibroblastic tumor of the liver manifesting with biloma: A case report. Huang K; Zhao P; Zhao J; Zhao P; Yang J Oncol Lett; 2022 Jul; 24(1):227. PubMed ID: 35720485 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505 [TBL] [Abstract][Full Text] [Related]
16. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297 [TBL] [Abstract][Full Text] [Related]